Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.
about
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisRole of bacteria in oncogenesisFermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer?Vaccine against Helicobacter pylori: Inevitable approachThe human microbiome, asthma, and allergyCollateral damage: microbiota-derived metabolites and immune function in the antibiotic eraInfections and cancer: the "fifty shades of immunity" hypothesis.Blood pressure and stature in Helicobacter pylori positive and negative persons.Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection.Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism.Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori InfectionRace, African ancestry, and Helicobacter pylori infection in a low-income United States population.Predictive computational modeling of the mucosal immune responses during Helicobacter pylori infectionGastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical managementHelicobacter pylori homB, but not cagA, is associated with gastric cancer in IranGut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control studyWorldwide Population Structure, Long-Term Demography, and Local Adaptation of Helicobacter pylori.Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosisSignificant decrease in prevalence of Helicobacter pylori in the Czech Republic.Helicobacter pylori infection in India from a western perspective.The hallmarks of premalignant conditions: a molecular basis for cancer preventionUpper gastrointestinal cancer and reflux disease.Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses.Coadaptation of Helicobacter pylori and humans: ancient history, modern implications.Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?Novel insights on the role of CD8+ T cells and cytotoxic responses during Helicobacter pylori infection."Gastric cytoprotection" is still relevant.Factors shaping the composition of the cutaneous microbiota.Positive selection on a bacterial oncoprotein associated with gastric cancerInverse association between Helicobacter pylori and pediatric asthma in a high-prevalence population.Modifiable factors and esophageal cancer: a systematic review of published meta-analyses.An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.Risk factors of early proximal gastric carcinoma in Chinese diagnosed using WHO criteria.Morphologic and pharmacological investigations in the epicatechin gastroprotective effectPrevalence and determinants of Helicobacter pylori sero-positivity in the Australian adult community.Helicobacter pylori antibody responses and evolution of precancerous gastric lesions in a Chinese population.Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.Gastric microbiota: tracing the culprit.
P2860
Q24602426-B951C57D-FAE2-42A9-BBA2-0D010073F588Q24633180-9822A9F0-9ABF-46D8-9773-29D247DC7D0EQ26738441-827EA7D9-80B5-465B-8C8E-DC2CE5CDCAB4Q26752743-0818706F-8F80-43CA-828D-3071F6C15906Q26776270-0C5F5932-81C6-4EAA-8C39-05E4BE8F8FAFQ27000267-8F6100E8-FB44-49FB-9443-FBE0EC3C1A4FQ33555975-90D525E0-6C47-44DB-917D-9BED676D68BEQ33626768-53CEF9AF-C89E-4918-B96D-ECBF37A5E893Q33995331-F9972D84-8AC0-4AF3-9E11-B3F2DC9EC60FQ34483009-422FA798-B276-4001-9AE2-E2B1F401D8F0Q34494038-C46D6136-116E-45AE-B011-9D9FF08A00ABQ34949321-717D3A89-4C9C-4CF0-9671-30731A52F18AQ34988965-B5842488-1B85-42F0-8D5C-263513ABDDFAQ35013649-861917EE-B658-463F-B89F-CEDA3D176F82Q35057339-B477FB9D-1AA7-4506-8C00-368182970A05Q35192226-98C2F13F-88E5-4F5E-BAE3-64EF95C09CE0Q35544903-4CEB349C-B6CA-4C7F-BF82-D54E199CCD93Q35836559-661DF6E2-22F5-4D5C-B74F-6AF1838699F2Q35882384-44EDDF18-21B2-435C-BEB9-D81D4EDF4CABQ35945226-38B61C2E-69B1-4CE8-889A-A924666DE890Q36215570-28E50516-5FBE-46A0-AD2B-8C51D999C289Q36449962-26BF873A-9BBF-47AD-BB9E-3C1DBF560184Q36679858-9F052201-4682-4E51-87E8-704AAD527DDFQ36993480-A304E573-3C0F-4748-A2B2-3BE1057D0B27Q37264581-582B6CA6-22B7-4E99-A91C-2AACF26AF5F1Q37328454-18892BC6-E538-48C7-9A81-7B39A25F955AQ38150281-6DB4F34D-3010-4068-BF57-2BE5A4B00ADEQ38206370-9877E2EB-063B-42C5-93D6-A6FD3D5F9EA5Q38293038-80687507-DFB3-485B-80B6-E5F12CD5878DQ38926007-820F7822-A9F9-4260-9A4B-F2F24B4CC2C1Q39535480-4A05A3F8-05B2-42F3-96E0-63C7FEBAF186Q40014909-79AAF03C-B7F5-41C5-B68B-6C7F407DA162Q40087448-A838F795-842C-46AE-AE4C-ED4F09A5BCDEQ40468473-8C7FDF5C-181E-44EA-93C2-705548373C01Q41441371-63C9D5E7-4DB9-4BC0-B9F5-0EC823E8BC58Q41949697-748ECCA2-C8CB-494F-9973-696CECB38EC8Q43506032-56E225CF-6B88-455D-9426-C971C2DAC40AQ44057966-A5B5664D-6B70-4972-918D-EA92F585C658Q45345471-E49A9C3A-D9CA-4882-8FF0-9C64FE809467Q46258930-CD5FBE4D-CFAE-4F64-AA87-8C13DB21ED79
P2860
Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@ast
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@en
type
label
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@ast
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@en
prefLabel
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@ast
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@en
P1476
Disappearing microbiota: Helic ...... nst esophageal adenocarcinoma.
@en
P304
P356
10.1158/1940-6207.CAPR-08-0170
P577
2008-10-01T00:00:00Z